Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off
BridgeBio Shares Fall As Initial-Stage Rare Metabolic Disorder Study Kicks-off
Palisade Bio Shares Drop Following Commencement Of Late-Stage Return Of Bowel Study
Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
Patient Enrollment Recent News
Virios Therapeutics Commences Mid-Stage Long-COVID Study
Avalo Therapeutics' Shares Climb Following Patient Dosing in Immunodeficiency Disorder Study
Kymera Therapeutics Commences Initial-Stage Oncology Trials
Apellis Begins Paitent Dosing In Late-Stage Study Of Rare Kidney Disease Candidate
Moderna Commences Late-stage Study of Flu Vaccine Candidate